APRIL WALLACE: Open Payments
NPI 1427564079 · NORTON, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$546 in 13 payments from 7 companies in 2025. Trend: 2023 $708 · 2024 $85 · 2025 $546
Education: $346Food & beverage: $200
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 3 | $320 |
| Celgene Corporation | 2 | $53 |
| Alexion Pharmaceuticals, Inc. | 2 | $43 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $42 |
| Caris MPI, Inc. | 2 | $42 |
| Merck Sharp & Dohme LLC | 1 | $26 |
| Daiichi Sankyo Inc. | 1 | $19 |
Products named: REBLOZYL, ULTOMIRIS, Nubeqa, MI CANCER SEEK, LYNPARZA, DATROWAY.
Industry payments across VA — which companies pay providers there.
